Verasonics Expands Leadership Team

Verasonics Inc. has expanded its leadership team with the appointment of Don Christopher, Ph.D., as chief technology officer (CTO), Stacy Douthitt as chief business officer (CBO), and Alex Exposito as Commercial Sales director. Ken Linkhart, Verasonics’ former CTO, is continuing with the company as its first Technical Fellow.
 
“I am pleased to welcome Don, Stacy and Alex to the Verasonics Team,” Verasonics President/CEO Jon K. Daigle said. “Their collective and broad expertise across technology, product development, and sales and marketing significantly strengthen our core capabilities. As we look to the future, we are focused on advancing the features and functionality of the Vantage Research Ultrasound System to continue to address the needs of our customers while further accelerating sales growth in academic and commercial entities. With these additions and changes to our team, we will continue to fuel our pursuit of these objectives and extend our leadership position in the research ultrasound arena.”
 
Dr. Christopher joined the Verasonics’ team in April 2021 as vice president of Engineering. He has more than 35 years’ experience in ultrasound product development and research leadership roles at renowned medical imaging commercial companies including ATL Ultrasound, Philips Medical Systems, Kona Medical, FUJIFILM SonoSite, and Siemens Healthineers. In addition to his role as CTO, he is also responsible for engineering, operations, quality, and regulatory. Dr. Christopher earned his master of science degree and doctorate in medical biophysics in medical imaging from the University of Toronto.
 
Douthitt is a senior marketing leader with 30 years of demonstrated results in commercial strategy and global marketing for medical device and life science firms. Prior to Verasonics, she held leadership positions at several medtech companies ranging from startup to Fortune 500. She has helped to lead four startups to successful exits. Douthitt is also responsible for customer success, product marketing and communications, as well as strategic marketing and alliances. She earned a bachelor of arts degree in marketing from the University of Washington, and an MBA from the University of Phoenix.
 
Exposito is a bilingual healthcare sales leader with more than 25 years of experience in driving the growth and development of innovative medical and research technologies used to improve healthcare. Prior to Verasonics, he was vice president of Sales at EchoLight Medical, a developer of bone densitometry solutions. Exposito has also held clinical, sales and executive positions at leading ultrasound companies and is a diagnostic medical sonographer. He earned a bachelor of science degree in administration with a specialization in health services and is an MBA candidate.
 
Verasonics is a privately held company founded in 2001, with headquarters in Kirkland, Wash. Verasonics is the leader in research ultrasound and is focused on providing researchers and developers with the most advanced and flexible tools enabling them to develop new algorithms and products used in biomedical ultrasound, materials science, earth sciences, and the physics of acoustics and ultrasonics. Verasonics also licenses its technology to companies for use in their commercial products. Researchers in nearly 40 countries across North and South America, Europe, Asia and Oceania routinely use Verasonics product solutions to advance the art and science of ultrasound through their own research efforts.